Search

IRBM Azole SHP2 Inhibitors Patent EP4345101A1

The European Patent Office published patent application EP4345101A1, filed by IRBM S.P.A. and C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening, covering azole derivatives as SHP2 inhibitors for therapeutic use. The application includes claims for treating cancer, immune disorders, and respiratory conditions, with inventors including Alessia Petrochchi, Christian Montalbetti, Romano Di Fabio, Alina Ciammaichella, and Ilaria Rossetti. The publication is designated for all European member states.